Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034925.xml
Download PDF
Hamostaseologie 2008; 28(S 01): S107-S108
DOI: 10.1055/s-0037-1621633
DOI: 10.1055/s-0037-1621633
Original article
Low molecular weight heparin in pregnancy
Influence on birth weight and duration of pregnancy in women with thrombophiliaNiedermolekulares Heparin in der SchwangerschaftEinfluss auf Geburtsgewicht und Schwangerschaftsdauer bei Frauen mit einer ThrombophilieFurther Information
Publication History
Publication Date:
04 January 2018 (online)
-
References
- 1 Bates SM, Greer IA, Hirsh J. et al. Use of anti-thrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (03) 627S-644S.
- 2 Bauersachs RM, Dudenhausen J, Faridi A. et al. and the EThIG Investigators. Risk, stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007; 98 (06) 1237-1245.
- 3 Brenner B. Clinical management of thrombophilia-related placental vascular complications. Blood 2004; 103: 4003-4009.
- 4 Robertson L, Wu O, Langhorne P. et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132: 171-196.